Dose Ranging Study to Evaluate the Efficacy and Safety of SAR153191 (REGN88) in Patients With Ankylosing Spondylitis

PHASE2CompletedINTERVENTIONAL
Enrollment

301

Participants

Timeline

Start Date

February 28, 2010

Primary Completion Date

June 30, 2011

Study Completion Date

June 30, 2011

Conditions
Ankylosing Spondylitis
Interventions
DRUG

Sarilumab

"Pharmaceutical form: Solution for injection~Route of administration: Subcutaneous"

DRUG

Placebo

"Pharmaceutical form: Solution for injection~Route of administration: Subcutaneous"

Trial Locations (80)

1020

Investigational Site Number 056003, Brussels

1023

Investigational Site Number 348001, Budapest

1100

Investigational Site Number 040002, Vienna

3000

Investigational Site Number 056002, Leuven

3145

Investigational Site Number 036001, Malvern East

3600

Investigational Site Number 056005, Genk

3980

Investigational Site Number 348005, Sátoraljaújhely

4000

Investigational Site Number 056004, Liège

4032

Investigational Site Number 348003, Debrecen

4102

Investigational Site Number 036002, Woolloongabba

6008

Investigational Site Number 036004, Shenton Park

7001

Investigational Site Number 036003, Hobart

8036

Investigational Site Number 040001, Graz

8200

Investigational Site Number 348004, Veszprém

9000

Investigational Site Number 056001, Ghent

12200

Investigational Site Number 276002, Berlin

12206

Investigational Site Number 840016, Albany

12850

Investigational Site Number 203001, Prague

13210

Investigational Site Number 840036, Syracuse

15006

Investigational Site Number 724004, A Coruña

16635

Investigational Site Number 840014, Duncansville

18015

Investigational Site Number 840023, Bethlehem

20902

Investigational Site Number 840003, Wheaton

22081

Investigational Site Number 276005, Hamburg

23320

Investigational Site Number 840034, Chesapeake

25030

Investigational Site Number 250001, Besançon

28007

Investigational Site Number 724002, Madrid

32806

Investigational Site Number 840032, Orlando

33076

Investigational Site Number 250005, Bordeaux

33486

Investigational Site Number 840009, Boca Raton

34102

Investigational Site Number 840001, Naples

35205

Investigational Site Number 840006, Birmingham

35340

Investigational Site Number 792001, Izmir

41008

Investigational Site Number 724001, Seville

43606

Investigational Site Number 840010, Toledo

44652

Investigational Site Number 276001, Herne

48823

Investigational Site Number 840008, Lansing

50005

Investigational Site Number 203002, Hradec Králové

60590

Investigational Site Number 276003, Frankfurt am Main

61201

Investigational Site Number 840021, Rock Island

63141

Investigational Site Number 840002, St Louis

63800

Investigational Site Number 203003, Brno

68601

Investigational Site Number 203004, Uherské Hradiště

73109

Investigational Site Number 840005, Oklahoma City

74801

Investigational Site Number 203005, Hlučín

75014

Investigational Site Number 250003, Paris

75231

Investigational Site Number 840004, Dallas

77034

Investigational Site Number 840030, Houston

83702

Investigational Site Number 840015, Boise

90048

Investigational Site Number 840027, Los Angeles

91054

Investigational Site Number 276004, Erlangen

91786

Investigational Site Number 840017, Upland

92108

Investigational Site Number 840007, San Diego

92801

Investigational Site Number 840033, Anaheim

94010

Investigational Site Number 250002, Créteil

94143

Investigational Site Number 840013, San Francisco

66160-7321

Investigational Site Number 840018, Kansas City

01655

Investigational Site Number 840029, Worcester

07728

Investigational Site Number 840028, Freehold

N6A 4V2

Investigational Site Number 124007, London

H2L 1S6

Investigational Site Number 124004, Montreal

L3Y 3R7

Investigational Site Number 124008, Newmarket

H9R 3Z2

Investigational Site Number 124003, Pointe-Claire

G1V 4R4

Investigational Site Number 124001, Québec

S7K 0H6

Investigational Site Number 124006, Saskatoon

M5T 2S8

Investigational Site Number 124005, Toronto

G8Z 1Y2

Investigational Site Number 124009, Trois-Rivières

V5Z 1L7

Investigational Site Number 124002, Vancouver

V5Z 3Y1

Investigational Site Number 124010, Vancouver

LT-50009

Investigational Site Number 440001, Kaunas

LT-08661

Investigational Site Number 440002, Vilnius

1105 AZ

Investigational Site Number 528001, Amsterdam

6525 GA

Investigational Site Number 528002, Nijmegen

15-354

Investigational Site Number 616002, Bialystok

30-510

Investigational Site Number 616001, Krakow

20-607

Investigational Site Number 616004, Lublin

87-100

Investigational Site Number 616005, Torun

02-637

Investigational Site Number 616003, Warsaw

08907

Investigational Site Number 724005, Barcelona

06100

Investigational Site Number 792002, Ankara

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Regeneron Pharmaceuticals

INDUSTRY

lead

Sanofi

INDUSTRY